| Registry | NCT05729269 |
|---|---|
| Status | Completed |
| Study type | Observational |
| Enrollment | 283 (Actual) |
| Sponsor | Chuncheon Sacred Heart Hospital (Other); collaborators: Dongtan Sacred Heart Hospital, Hallym University Medical Center, Hangang Sacred Heart Hospital, Kangdong Sacred Heart Hospital, Yonsei University |
| Conditions | Gastrointestinal Microbiome, Sarcopenia, Liver Disease Chronic |
| Interventions | Sarcopenia_CT (Diagnostic test) |
| Dates | start 2017-03-22, primary completion 2019-04-30, completion 2021-12-31, first posted 2023-02-15, last updated 2023-02-15 |
| Locations | 1 site in South Korea |
Related Papers Related Patents Related Grants Related Experts
All trials for Gastrointestinal Microbiome All trials for Sarcopenia All trials of Sarcopenia_CT
The purpose of this study was to confirm the presence of specific gut microbiota observed in patients with sarcopenia among patients who agreed to analyze gut microbiota through stool among multi-center chronic liver disease cohort patients.
The effect of gut microbiota on liver disease is also well known and many studies are ongoing. A recently published study summarized the differences in the composition of gut microbiota in non-alcoholic fatty liver, steatohepatitis, and cirrhosis, and reported that metabolites from the changed gut microbiota may be a factor influencing non-alcoholic fatty liver disease (NAFLD) progression. These changes in gut microbiota composition have been reported to affect clinical outcomes in patients by causing an increase in endotoxin, a change in bile acid metabolism, and a decrease in short chain fatty acid. In particular, the reduction of short chain fatty acid is known to be associated with the occurrence of sarcopenia. Sarcopenia, which is common in patients with cirrhosis, which is a representative chronic liver disease, is well known as a poor prognostic factor for patients. Therefore, this study aims to analyze the distribution of gut microbiota observed in patients with sarcopenia through the gut microbiota investigated in the chronic liver disease cohort patient group and the characteristics of the distribution of gut microbiota for each disease corresponding to chronic liver disease.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Chronic liver disease | Diagnostic Test: Sarcopenia_CT | non-alcohol liver disease, alcohol liver disease, liver cirrhosis |
Sex: All, ages: 24 Years to 82 Years
Inclusion Criteria: * 1\. Patients who have chronic liver disease (chronic liver disease cohort): alcohol liver disease, non-alcoholic liver disease, liver cirrhosis 2. Patients who consented to a study confirming the gut microbiota 3. Patients with abdominal computed tomography scan taken one month before or after submitting stool for gut microbiota analysis Exclusion Criteria: * Patients whose height and weight records are missing from the chart review
| Facility | City | Country | Status |
|---|---|---|---|
| Department of Internal Medicine, Hallym University Medical College | Chuncheon, Gangwon-do | South Korea |